Gene Therapy Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Gene Therapy stocks.

Gene Therapy Stocks Recent News

Date Stock Title
May 10 MGTX MeiraGTx Holdings PLC Reports First Quarter 2024 Financial Results
May 10 NKTX Nkarta Inc (NKTX) Reports Q1 2024 Earnings: A Detailed Financial and Operational Analysis
May 10 MGTX MeiraGTx Holdings First Quarter 2024 Earnings: US$0.32 loss per share (vs US$0.62 loss in 1Q 2023)
May 9 NKTX Nkarta GAAP EPS of -$0.58 misses by $0.02
May 9 NKTX Nkarta Reports First Quarter 2024 Financial Results and Corporate Highlights
May 9 MGTX MeiraGTx GAAP EPS of -$0.32, revenue of $0.69M
May 9 LXEO Lexeo Therapeutics reports Q1 results
May 9 MGTX MeiraGTx Reports First Quarter 2024 Financial and Operational Results
May 9 CRGX Is There An Opportunity With CARGO Therapeutics, Inc.'s (NASDAQ:CRGX) 21% Undervaluation?
May 9 LXEO Lexeo Therapeutics Reports First Quarter 2024 Financial Results and Operational Highlights
May 9 ANIX Anixa expands cancer vaccine collaboration with Cleveland Clinic
May 8 TSVT 2seventy bio, Inc. (TSVT) Q1 2024 Earnings Call Transcript
May 8 ANIX Anixa Biosciences enters JV with Cleveland Clinic for additional cancer vaccines
May 8 ANIX Anixa Biosciences Expands Partnership with Cleveland Clinic to Develop Additional Cancer Vaccines
May 8 TSVT 2seventy bio GAAP EPS of -$1.01 misses by $0.20, revenue of $12.4M misses by $1.69M
May 8 TSVT 2seventy bio Reports First Quarter Financial Results and Recent Operational Progress
May 8 VYGR Voyager Therapeutics Presents Data for Second-Generation, TRACERâ„¢-Generated Capsids and CNS Gene Therapy Programs Advancing Toward Clinical Trials at the ASGCT 27th Annual Meeting
May 7 TSVT 2seventy bio Q1 2024 Earnings Preview
May 7 ANIX Sidoti Events, LLC's Virtual May Micro-Cap Conference
May 7 LXEO Lexeo Therapeutics to Participate in Upcoming Investor Conferences
Gene Therapy

In the medicine field, gene therapy (also called human gene transfer) is the therapeutic delivery of nucleic acid into a patient's cells as a drug to treat disease. The first attempt at modifying human DNA was performed in 1980 by Martin Cline, but the first successful nuclear gene transfer in humans, approved by the National Institutes of Health, was performed in May 1989. The first therapeutic use of gene transfer as well as the first direct insertion of human DNA into the nuclear genome was performed by French Anderson in a trial starting in September 1990.
Between 1989 and February 2016, over 2,300 clinical trials were conducted, with more than half of them in phase I.
Not all medical procedures that introduce alterations to a patient's genetic makeup can be considered gene therapy. Bone marrow transplantation and organ transplants in general have been found to introduce foreign DNA into patients. Gene therapy is defined by the precision of the procedure and the intention of direct therapeutic effect.

Browse All Tags